Synsam AB
Synsam AB (publ), together with its subsidiaries, operates in the optical retail and eye health sector in the Nordic Region. The company offers lenses, frames, sunglasses, sports spectacles, contact lenses, eye care accessories, and hearing aids. It also provides eye health services, hearing tests, lifestyle subscriptions, contact lens subscriptions, personal style advice services, and eye examin… Read more
Synsam AB (SYNSAM) - Net Assets
Latest net assets as of September 2025: Skr2.46 Billion SEK
Based on the latest financial reports, Synsam AB (SYNSAM) has net assets worth Skr2.46 Billion SEK as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr7.88 Billion) and total liabilities (Skr5.42 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr2.46 Billion |
| % of Total Assets | 31.27% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 2.83 |
Synsam AB - Net Assets Trend (2018–2024)
This chart illustrates how Synsam AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Synsam AB (2018–2024)
The table below shows the annual net assets of Synsam AB from 2018 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Skr2.56 Billion | +1.55% |
| 2023-12-31 | Skr2.52 Billion | -2.63% |
| 2022-12-31 | Skr2.58 Billion | +4.24% |
| 2021-12-31 | Skr2.48 Billion | +257.44% |
| 2020-12-31 | Skr-1.57 Billion | -14.78% |
| 2019-12-31 | Skr-1.37 Billion | -14.63% |
| 2018-12-31 | Skr-1.20 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Synsam AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 24330000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr1.00 Million | 0.04% |
| Other Comprehensive Income | Skr112.00 Million | 4.38% |
| Other Components | Skr4.31 Billion | 168.53% |
| Total Equity | Skr2.56 Billion | 100.00% |
Synsam AB Competitors by Market Cap
The table below lists competitors of Synsam AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Direcional Engenharia S.A.
SA:DIRR3
|
$731.83 Million |
|
Yili Chuanning Biotechnology Co. Ltd. A
SHE:301301
|
$731.85 Million |
|
Maharashtra Scooters Limited
NSE:MAHSCOOTER
|
$731.91 Million |
|
Energisa S.A
SA:ENGI3
|
$732.17 Million |
|
Harbin Electric Coporation Jiamusi Electric Machine Co Ltd
SHE:000922
|
$731.00 Million |
|
Beijing Haitian Ruisheng Science Technology Ltd
SHG:688787
|
$730.72 Million |
|
Heritage Commerce Corp
NASDAQ:HTBK
|
$730.72 Million |
|
Shanghai Medicilon Inc
SHG:688202
|
$730.34 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Synsam AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,516,000,000 to 2,555,000,000, a change of 39,000,000 (1.6%).
- Net income of 366,000,000 contributed positively to equity growth.
- Dividend payments of 266,000,000 reduced retained earnings.
- Share repurchases of 85,000,000 reduced equity.
- Other comprehensive income increased equity by 17,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr366.00 Million | +14.32% |
| Dividends Paid | Skr266.00 Million | -10.41% |
| Share Repurchases | Skr85.00 Million | -3.33% |
| Other Comprehensive Income | Skr17.00 Million | +0.67% |
| Other Changes | Skr7.00 Million | +0.27% |
| Total Change | Skr- | 1.55% |
Book Value vs Market Value Analysis
This analysis compares Synsam AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.91x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | Skr-7.98 | Skr67.70 | x |
| 2019-12-31 | Skr-9.15 | Skr67.70 | x |
| 2020-12-31 | Skr-10.50 | Skr67.70 | x |
| 2021-12-31 | Skr16.53 | Skr67.70 | x |
| 2022-12-31 | Skr17.25 | Skr67.70 | x |
| 2023-12-31 | Skr16.88 | Skr67.70 | x |
| 2024-12-31 | Skr17.30 | Skr67.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Synsam AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.32%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.69%
- • Asset Turnover: 0.78x
- • Equity Multiplier: 3.23x
- Recent ROE (14.32%) is above the historical average (5.92%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 0.00% | -8.78% | 0.53x | 0.00x | Skr-179.93 Million |
| 2019 | 0.00% | -4.71% | 0.55x | 0.00x | Skr-40.82 Million |
| 2020 | 0.00% | -5.06% | 0.53x | 0.00x | Skr-37.74 Million |
| 2021 | 2.06% | 1.08% | 0.62x | 3.07x | Skr-196.90 Million |
| 2022 | 12.69% | 6.13% | 0.67x | 3.10x | Skr69.60 Million |
| 2023 | 12.36% | 5.27% | 0.73x | 3.19x | Skr59.40 Million |
| 2024 | 14.32% | 5.69% | 0.78x | 3.23x | Skr110.50 Million |
Industry Comparison
This section compares Synsam AB's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $376,322,575
- Average return on equity (ROE) among peers: -23.29%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Synsam AB (SYNSAM) | Skr2.46 Billion | 0.00% | 2.20x | $731.69 Million |
| AddLife AB (publ) (ALIF-B) | $1.89 Billion | 27.39% | 1.20x | $1.42 Billion |
| Biotage AB (BIOT) | $476.77 Million | 8.68% | 0.24x | $787.18 Million |
| Bonesupport Holding AB (BONEX) | $124.31 Million | -129.56% | 0.58x | $897.79 Million |
| Dynavox Group (DYVOX) | $210.60 Million | 23.08% | 5.28x | $786.85 Million |
| iZafe Group AB Series B (IZAFE-B) | $9.04 Million | -35.07% | 0.67x | $12.58 Million |
| Ortivus AB ser. A (ORTI-A) | $84.63 Million | -21.84% | 0.94x | $1.20 Million |
| S2Medical AB (S2M) | $25.11 Million | -73.41% | 0.22x | $641.00K |
| Stille AB (STIL) | $189.81 Million | 14.40% | 0.80x | $82.32 Million |